Luminicell is a Singapore-based biotechnology company that specializes in advanced biocompatible fluorescent probes for long-term live cell, deep-tissue bio-imaging and diagnostics applications with exceptional sensitivity.

Founded in 2014, Luminicell manufactures fluorescent lipid nanoparticles with its patented encapsulation platform technology, combining it with novel Aggregation-Induced Emission (AIE) molecular powering its next-generation, ultra-bright fluorescent AIEdot™ trackers. AIEdots exhibit outstanding photostability, enabling continuous monitoring of biological processes and unlocking long-term imaging for both in vitro and in vivo applications.

At Luminicell, we are dedicated to providing our customers with the best performing fluorescent nanoparticles, unlocking information that are now made achievable with our products, yielding superior results to accelerate all fields of biomedical research. Our platform technology are highly tuneable, allowing users to achieve their unique application needs. 

Luminicell is a wholly owned subsidiary of Nanolumi.